Regeneron Pharmaceuticals REGN
NASDAQ REGN
$790.74 -5.60 (-0.70%)
At close: Oct 16, 2026 · 4:00 PM EDT

Regeneron Pharmaceuticals (REGN) Other Non Operating Income (2013 - 2026)

Updated

Regeneron Pharmaceuticals' Other Non Operating Income was $245.3 million in Q2 2026, down 44.6% from $442.8 million a year earlier but up 21.9% from the prior quarter.

Analysis

Regeneron Pharmaceuticals (REGN) Other Non Operating Income (2013 - 2026) Analysis & Trends

On a trailing twelve-month basis, Regeneron Pharmaceuticals' Other Non Operating Income was $1.38 billion through Jun 30, 2026, up 28.8% year-over-year; for FY2025, it was $1.7 billion, up 100.9% from FY2024.

  • Other Non Operating Income has now increased for three consecutive years, with a five-year compound annual growth rate of 42.3% (FY2020 to FY2025).
  • In earlier years, Other Non Operating Income was $844.4 million in FY2024 (+275.0%), $225.2 million in FY2023 (+25.6%), $179.3 million in FY2022 (-58.9%) and $436.3 million in FY2021 (+50.1%).
  • Quarterly Other Non Operating Income has moved between -$183.8 million (Q1 2022) and $755.8 million (Q3 2025) over five years.
  • Compared with a year earlier, Other Non Operating Income was higher in 1 of the last four quarters, with growth averaging 6.5%.
  • Per Business Quant data, REGN's Other Non Operating Income in the three quarters before Q2 2026 was $201.2 million (Q1 2026), $176 million (Q4 2025) and $755.8 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn
10 Regeneron Pharmaceuticals 81.27 Bn 47.47 Bn 3.71 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 245.30 Mn
Mar 31, 2026 201.20 Mn
Dec 31, 2025 176.00 Mn
Sep 30, 2025 755.80 Mn
Jun 30, 2025 442.80 Mn
Mar 31, 2025 322.00 Mn
Dec 31, 2024 -21.60 Mn
Sep 30, 2024 327.30 Mn
Jun 30, 2024 573.30 Mn
Mar 31, 2024 -34.60 Mn
Dec 31, 2023 193.00 Mn
Sep 30, 2023 17.60 Mn
Jun 30, 2023 85.30 Mn
Mar 31, 2023 -70.70 Mn
Dec 31, 2022 195.30 Mn
Sep 30, 2022 301.40 Mn
Jun 30, 2022 -133.60 Mn
Mar 31, 2022 -183.80 Mn
Dec 31, 2021 -122.20 Mn
Sep 30, 2021 -16.40 Mn
API Access

Regeneron Pharmaceuticals Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=REGN&period=max&api_key=YOUR_API_KEY